Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients

European Journal of Cancer

Volumn 44, Issue 15, 2008, Pages 2259-2265

  Mann, Andrea ^a   Hogdall, Estrid ^b   Ramus, Susan J ^c   DiCioccio, Richard A ^d   Hogdall, Claus ^e   Quaye, Lydia ^c   McGuire, Valerie ^f   Whittemore, Alice S ^f   Shah, Mitul ^a   Greenberg, David ^g   Easton, Douglas F ^a   Ponder, Bruce A J ^a   Kjaer, Susanne Krüger ^b,e   Gayther, Simon A ^c   Thompson, Deborah J ^a   Pharoah, Paul D P ^a   Song, Honglin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Eastern Cancer Registration and Information Centre   (United Kingdom)

Author keywords

Mismatch repair; Ovarian cancer; SNPs; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CASE CONTROL STUDY; DENMARK; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISMATCH REPAIR; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; UNITED KINGDOM; UNITED STATES; UNIVARIATE ANALYSIS;

ADULT; DNA MISMATCH REPAIR; DNA REPAIR; DNA, NEOPLASM; EPIDEMIOLOGIC METHODS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 53049089158     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.07.010     Document Type: Article

References (29)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J Clin 55 (2005) 74-108
2. Spurdle A.B., Hopper J.L., Chen X., et al. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer Epidemiol Biomarkers Prev 10 (2001) 1287-1293
3. Hefler L.A., Mustea A., Konsgen D., et al. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res 13 (2007) 898-901
4. Gadducci A., Di Cristofano C., Zavaglia M., et al. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel-plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res 26 (2006) 687-693
5. Obata H., Yahata T., Quan J., Sekine M., and Tanaka K. Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer. Anticancer Res 26 (2006) 2227-2232
6. Hogdall E.V., Kjaer S.K., Glud E., et al. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" ovarian cancer study. Anticancer Res 23 (2003) 3397-3404
7. Higashi T., Kyo S., Inoue M., Tanii H., and Saijoh K. Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer. J Mol Diagn 8 (2006) 342-350
8. Green H., Soderkvist P., Rosenberg P., Horvath G., and Peterson C. mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin Cancer Res 12 (2006) 854-859
9. Beeghly A., Katsaros D., Chen H., et al. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100 (2006) 330-337
10. Baekelandt M., Kristensen G.B., Nesland J.M., Trope C.G., and Holm R. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J Clin Oncol 17 (1999) 2061-2068
11. Nagle C.M., Chenevix-Trench G., Webb P.M., and Spurdle A.B. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes. Cancer Lett 251 (2007) 96-104
12. Garg R., Wollan M., and Galic V. Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma. Gynecol Oncol 103 (2006) 793-796
13. Song H., Hogdall E., Ramus S.J., et al. Effects of common germline genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res 14 4 (2008) 1090-1095
14. Galic V., Willner J., Wollan M., et al. Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas. Genes Chromosomes Cancer 46 (2007) 239-247
15. Dhar K.K., Branigan K., Howells R.E., et al. Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer 9 (1999) 342-347
16. Pharoah P.D., Dunning A.M., Ponder B.A., and Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4 (2004) 850-860
17. Drake A.C., Campbell H., Porteous M.E., and Dunlop M.G. The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer. Int J Gynecol Cancer 13 (2003) 262-277
18. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 21 (2003) 1174-1179
19. de la C.A. Microsatellite instability. N Engl J Med 349 (2003) 209-210
20. Buermeyer A.B., Deschenes S.M., Baker S.M., and Liskay R.M. Mammalian DNA mismatch repair. Annu Rev Genet 33 (1999) 533-564
21. Chen Y., Wang J., and Fraig M.M. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol 22 (2003) 1033-1043
22. Park J.G., Park Y.J., Wijnen J.T., and Vasen H.F. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. Int J Cancer 82 (1999) 516-519
23. Yamamoto H., Perez-Piteira J., Yoshida T., Terada M., et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 116 (1999) 1348-1357
24. Peltomaki P. DNA mismatch repair and cancer. Mutat Res 488 (2001) 77-85
25. Hsu H.S., Lee I.H., Hsu W.H., Kao W.T., and Wang Y.C. Polymorphism in the hMSH2 gene (gISV12-6T > C) is a prognostic factor in non-small cell lung cancer. Lung Cancer 58 (2007) 123-130
26. Song H., Ramus S.J., Quaye L., et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 11 (2006) 2235-2242
27. Lum A., and Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 7 (1998) 719-724
28. Wang M.C., Brookmeyer R., and Jewell N.P. Statistical models for prevalent cohort data. Biometrics 49 (1993) 1-11
29. Pe'er I., de Bakker P.I., Maller J., et al. Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet 38 (2006) 663-667